DE69901721T2 - Pharmazeutische zusammensetzungen basierend auf alpha-cyclodextrin zur oralen verabreichung von lh-rh analogen - Google Patents

Pharmazeutische zusammensetzungen basierend auf alpha-cyclodextrin zur oralen verabreichung von lh-rh analogen

Info

Publication number
DE69901721T2
DE69901721T2 DE69901721T DE69901721T DE69901721T2 DE 69901721 T2 DE69901721 T2 DE 69901721T2 DE 69901721 T DE69901721 T DE 69901721T DE 69901721 T DE69901721 T DE 69901721T DE 69901721 T2 DE69901721 T2 DE 69901721T2
Authority
DE
Germany
Prior art keywords
cyclodextrin
analogs
alpha
pharmaceutical compositions
oral administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69901721T
Other languages
English (en)
Other versions
DE69901721D1 (de
Inventor
Remi Delansorne
Paule Bonnet
Jacques Paris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Theramex SAM
Original Assignee
Laboratoire Theramex SAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM
Publication of DE69901721D1 publication Critical patent/DE69901721D1/de
Application granted granted Critical
Publication of DE69901721T2 publication Critical patent/DE69901721T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
DE69901721T 1998-09-30 1999-09-23 Pharmazeutische zusammensetzungen basierend auf alpha-cyclodextrin zur oralen verabreichung von lh-rh analogen Expired - Lifetime DE69901721T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98402403A EP0998940A1 (de) 1998-09-30 1998-09-30 Pharmazeutische zusammensetzung basierend auf alpha-cyclodextrin für die orale verabreichung von LH-RH analogen
PCT/EP1999/007389 WO2000018423A1 (en) 1998-09-30 1999-09-23 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues

Publications (2)

Publication Number Publication Date
DE69901721D1 DE69901721D1 (de) 2002-07-11
DE69901721T2 true DE69901721T2 (de) 2003-01-09

Family

ID=8235503

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69901721T Expired - Lifetime DE69901721T2 (de) 1998-09-30 1999-09-23 Pharmazeutische zusammensetzungen basierend auf alpha-cyclodextrin zur oralen verabreichung von lh-rh analogen

Country Status (28)

Country Link
EP (2) EP0998940A1 (de)
JP (1) JP4485060B2 (de)
KR (1) KR100652457B1 (de)
CN (1) CN1200727C (de)
AR (1) AR023056A1 (de)
AT (1) ATE218358T1 (de)
AU (1) AU756233B2 (de)
BR (1) BR9914125A (de)
CA (1) CA2344470C (de)
CZ (1) CZ302343B6 (de)
DE (1) DE69901721T2 (de)
DK (1) DK1117420T3 (de)
EE (1) EE04872B1 (de)
ES (1) ES2178478T3 (de)
HK (1) HK1042047B (de)
HU (1) HUP0103649A3 (de)
ID (1) ID28650A (de)
IL (2) IL142112A0 (de)
MX (1) MXPA01003340A (de)
NO (1) NO330234B1 (de)
NZ (1) NZ510446A (de)
PL (1) PL200693B1 (de)
PT (1) PT1117420E (de)
RU (1) RU2214270C2 (de)
SI (1) SI1117420T1 (de)
TR (1) TR200100887T2 (de)
WO (1) WO2000018423A1 (de)
ZA (1) ZA200102452B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
SE0104462D0 (sv) 2001-12-29 2001-12-29 Carlbiotech Ltd As Peptide purifcation (Peptidrening)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
US4659969A (en) * 1984-08-09 1987-04-21 Synektron Corporation Variable reluctance actuator having position sensing and control
PT88490B (pt) * 1987-09-14 1992-11-30 Novo Nordisk As Processo para a preparacao de composicoes farmaceuticas para libertacao nao-enterica trans-mucosa contendo monossacaridos ou oligossacaridos
SI9300470A (en) * 1993-09-10 1995-04-30 Lek Tovarna Farmacevtskih Inclusion complexes of optically active and racemic ibuproxan with cyclodextrin derivates,process for their preparation,pharmaceutical preparations comprising the same and their use
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
EP0839525B1 (de) * 1996-10-31 2004-08-04 Takeda Chemical Industries, Ltd. Zubereitung mit verzögerter Freisetzung
EP0842946A1 (de) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. LHRH Analoge mit starrer Konformation, deren Verwendungen und pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
RU2214270C2 (ru) 2003-10-20
IL142112A (en) 2006-10-31
ATE218358T1 (de) 2002-06-15
NO20011576L (no) 2001-03-28
AU756233B2 (en) 2003-01-09
ES2178478T3 (es) 2002-12-16
CA2344470C (en) 2009-01-06
SI1117420T1 (en) 2002-12-31
WO2000018423A1 (en) 2000-04-06
NO330234B1 (no) 2011-03-07
PL200693B1 (pl) 2009-01-30
AR023056A1 (es) 2002-09-04
NZ510446A (en) 2003-01-31
EP1117420A1 (de) 2001-07-25
ID28650A (id) 2001-06-21
ZA200102452B (en) 2002-03-26
PT1117420E (pt) 2002-10-31
PL346939A1 (en) 2002-03-11
HUP0103649A3 (en) 2002-05-28
CN1324241A (zh) 2001-11-28
DE69901721D1 (de) 2002-07-11
CA2344470A1 (en) 2000-04-06
HK1042047B (zh) 2005-12-16
EE04872B1 (et) 2007-08-15
CZ302343B6 (cs) 2011-03-23
DK1117420T3 (da) 2002-09-16
CN1200727C (zh) 2005-05-11
KR20010075255A (ko) 2001-08-09
CZ20011173A3 (cs) 2001-09-12
JP2002525336A (ja) 2002-08-13
JP4485060B2 (ja) 2010-06-16
KR100652457B1 (ko) 2006-11-30
EP0998940A1 (de) 2000-05-10
EE200100196A (et) 2002-06-17
IL142112A0 (en) 2002-03-10
BR9914125A (pt) 2001-06-19
NO20011576D0 (no) 2001-03-28
AU6199999A (en) 2000-04-17
HUP0103649A2 (hu) 2002-02-28
MXPA01003340A (es) 2004-04-21
EP1117420B1 (de) 2002-06-05
TR200100887T2 (tr) 2001-10-22

Similar Documents

Publication Publication Date Title
DE69819205D1 (de) Orale pharmazeutische dosierungsform beruhend auf stossweiser freisetzung
ATE202280T1 (de) Filmbildende pharmazeutische zusammensetzungen zur transdermalen verabreichung
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
DE69733994D1 (de) Sauger zur medikamentenverabreichung
ATE404207T1 (de) Orale pharmazeutische zubereitung enthaltend ibandronat
ATE219377T1 (de) Neue galenische orale pharmazeutische formulierung
NO20022058D0 (no) Farmasöytiske sammensetninger
DE69212879T2 (de) Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren
DE69935681D1 (de) Vorrichtungen zur Medikamentverabreichung
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
ATA59499A (de) Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
DE69807768D1 (de) Rapamycin enthaltende Formulierungen zur oralen Verabreichung
DE60017175D1 (de) Ciclesonidhaltige arzneizusammensetzung zur verabreichung auf die schleimhäute
DE69614407T2 (de) Pharmazeutische zusammensetzungen
ATE260094T1 (de) Mikronisierte bicyclische arzneistoffe enthaltende pharmazeutische zusammensetzungen
DE69830154D1 (de) Pharmazeutische zusammensetzungen
DE69901721D1 (de) Pharmazeutische zusammensetzungen basierend auf alpha-cyclodextrin zur oralen verabreichung von lh-rh analogen
DE69825193D1 (de) Pyridazinon-Verbindungen enthaltenden Zusammensetzungen zur oralen Verabreichung
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
ITMI992202A0 (it) Composizioni farmaceutiche contenenti farmaci antiinfiammatori
DE69938347D1 (de) Medikamentöse verabreichung von nikotin in form von kaugummi
ITPD920141A1 (it) Formulazioni farmaceutiche per la somministraziane orale di calcitonina

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: LABORATOIRE THERAMEX, MONACO, MC

8364 No opposition during term of opposition